Author

C. F. Lusi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

G. I. Kane· 2 shared P. U. Atukorale· 2 shared A. Brown· 1 shared A. Monahan· 1 shared A. Nagar· 1 shared A. Nandy· 1 shared C. L. Grimes· 1 shared C. N. Parikh· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

G. I. Kane

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Nanoparticle delivery of innate immune agonists combines with senescence-inducing agents to mediate T cell control of pancreatic cancer

L. Chibaya, C. F. Lusi, K. D. DeMarco, G. I. Kane, M. L. Brassil, C. N. Parikh, K. C. Murphy, J. Li, T. E. Naylor, J. Cerrutti, J. Peura, J. R. Pitarresi, L. J. Zhu, K. A. Fitzgerald, P. U. Atukorale, M. A. Ruscetti

This paper combines nanoparticle-delivered immune agonists with senescence-inducing agents to enhance T cell responses and control pancreatic cancer in preclinical models.

bioRxiv · Sep 18, 2023 · PreprintCancer Biology

Methotrexate inhibition of muropeptide transporter SLC46A2 controls psoriatic skin inflammation

R. Bharadwaj, C. F. Lusi, S. Mashayekh, A. Nagar, R. K. S. Malireddi, G. I. Kane, K. Wodzanowski, A. Brown, K. Okuda, A. Monahan, D. Paik, A. Nandy, M. Anonick, W. E. Goldman, T.-D. Kanneganti, , N. Silverman

The paper shows that SLC46A2 transports DAP-muropeptides to activate NOD1 in keratinocytes, and methotrexate inhibits this transport, reducing psoriatic inflammation.

bioRxiv · Sep 29, 2022 · PreprintImmunology